



The prognostic value of somatosensory evoked
potentials in children after cardiac arrest
McDevitt, William; Rowberry, Tracey A.; Davies, Paul; Bill, Peter R.; Notghi, Lesley M.;




Creative Commons: Attribution-NonCommercial (CC BY-NC)
Document Version
Peer reviewed version
Citation for published version (Harvard):
McDevitt, W, Rowberry, TA, Davies, P, Bill, PR, Notghi, LM, Morris, K & Scholefield, B 2019, 'The prognostic
value of somatosensory evoked potentials in children after cardiac arrest: the SEPIA Study', Journal of Clinical
Neurophysiology. https://doi.org/10.1097/WNP.0000000000000649
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
This is a non-final version of an article published in final form in McDevitt, W, Rowberry, TA, Davies, P, Bill, PR, Notghi, LM, Morris, K &




Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.





The prognostic value of Somatosensory Evoked Potentials In children after cardiac Arrest:  
The SEPIA study 
Authors: William McDevitt (MSc)1, Tracey Rowberry (MSc)2, Paul Davies (PhD)3 Peter Bill (BSc)1, 
Lesley Notghi (MA, MB, ChB, MPhil)1, Kevin P Morris (MBBS, MRCP, MD, FRCPCH, FFICM )2,4, 
Barnaby R Scholefield (MBBS, MSc, BSc, MRCPCH, PhD)2,5 
Affiliations:  
1- Department of Neurophysiology, Birmingham Women’s and Children’s Hospital NHS 
Foundation Trust, UK 
2- Paediatric Intensive Care Unit, Birmingham Women’s and Children’s Hospital NHS 
Foundation Trust, UK 
3- Institute of Child Health, Birmingham Women’s and Children’s Hospital NHS Foundation 
Trust, UK 
4- Institute of Applied Health Research, University of Birmingham, UK 
5- Birmingham Acute Care Research Group, University of Birmingham, UK 
Corresponding author details 
William McDevitt, 
Department of Neurophysiology,  
Birmingham Women’s and Children’s Hospital NHS Foundation Trust, Steelhouse Lane, 
Birmingham, B4 6NH, UK. 
Tel: 0121 333 9260 
email: w.mcdevitt@nhs.net 
Conflicts of interest: None to declare 
Preliminary results of this study were presented at the 5th International Hypothermia and 
Temperature Management Symposium, Edinburgh, 7th-10th September 2014. 
RUNNING TITLE: The SEPIA study 
WORD COUNT (ABSTRACT): 248 250 
KEY WORDS: SOMATOSENSORY EVOKED POTENTIAL, TARGETED TEMPERATURE 
MANAGEMENT, PROGNOSIS, PAEDIATRICS, CARDIAC ARREST, HYPOXIC ISCHAEMIC INJURY 
Comment [MW(1]: Will doubvle check 





Introduction: Absent cortical somatosensory evoked potentials (SSEPs) reliably predict poor 
neurological outcome in adults post cardiac arrest (CA). However, there is less evidence to 
support this in children. In addition, targeted temperature management (TTM), test timing and 
a lack of blinding may affect test accuracy.  
Methods: A Single single centre, prospective cohort study of paediatric (aged 24-hours – 
15years) patients in which prognostic value of SSEPs were assessed 24, 48 & 72 hours post CA. 
TTM (33-34°C for 24 hours) followed by gradual rewarming to 37°C was used. SSEPs were 
graded as present, absent, or indeterminate and results blinded to clinicians. Neurological 
Ooutcome was graded as “Good” (score 1-3) or “Poor” (4-6) using the Paediatric Cerebral 
Performance Category (PCPC) scale 30 days post CA and blinded to SSEP interpreter.  
Results: 12 Twelve patients (Median age: 12 months; IQR:2-150; 92% Male) had SSEPs 
interpreted as absent (6/12) or present (6/12) <72 hours post CA. Outcome was good in 7/12 
(58%) and poor in 5/12 (42%). Absent SSEPs predicted poor neurological outcome in the 
majority of patients with 88% specificity (95%CI: 53%-98%)  . One patient with an absent SSEP 
had good (PCPC:3) outcome (Specificity: 88%; 95%CI: 53%-98%) and all patients with present 
SSEPs had good outcome (Sensitivity: 100%; 95%CI: 40%-100%). SSEP absence/presence was 
consistent across 24-(temperature=34°C) 48-(t=36°C) and 72-hour-(t=36°C) recordings post CA. 
Conclusions: In paediatric CA patients, blinded SSEPs did not accurately predict neurological 
outcome in one patient. Temperature of the patient and timing of the SSEP did not affect 
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Accurate prediction of neurological outcome in children who remain comatose after cardiac 
arrest (CA) is important as uncertainty may impair decision making, delay appropriate 
management and compound the stress and anxiety of families [1].  
SSEPs are well described and recommended to predicting poor outcome in adults post CA and 
bilaterally absent N20 potentials[2-3]. In 2014 previous practice parameters were updated to 
reflect changes in CA management (therapeutic hypothermia (TH)), advances in diagnostic 
imaging, such as  Electroencephalography and Magnetic resonance imaging (EEG, MRI) and 
address limitations in prognostic studies (self-fulfilling prophecy bias in unblinded studies). 
Bilateral absence of N20 potentials still  have have high specificity (>90%) and a false positive 
rate (FPR) between 0-3% [42-13]], with slightly higher FPRs in those treated with TH [5-6]. but  
However, a rrecent research systematic  suggestsreview suggested that false positive rates may 
be up to ten times higher than previously thought [Amorim et al, 2018]. Because paediatric 
cohorts were excluded from the review, we are still unsure as to what the false positive rate is 
in paediatric prognostic SSEPs. 
Currently SSEPs performed >72 hours post CA are used as part of multimodal prognostic 
algorithms but there is still a lack of blinded research in this field, [7-9]  and it is difficult to 
apply current guidelines and recommendations to paediatric practice because the evidence 
cited largely excludes those <16 years of age [4, 9-11]. Whilst test accuracy is similar in 
paediatrics [12] caution is advised when predicting poor outcome because awakening can occur 
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SSEPs They are generated via the summation of peripherally evoked potentials which synapse 
at the dorsal root entry zone of the spinal cord and ascend ipsilaterally to the cuneate nucleus, 
decussating below the level of the thalamus and travelling to the contralateral post-central 
gyrus/somatosensory cortex [14]. Electrographically, this is represented as a negative deflection 
occurring 20ms (N20) after upper limb stimulation and 35ms (N35) in lower limbs. If bilaterally 
absent, in the presence of peripheral and spinal potentials, severe neurological injury is 
indicated [14]. Although there is concern that low false positive rates and high-test specificity 
may be exaggerated due to unblinded studies, guidelines recommend their use when predicting 
poor outcome in comatose CA survivors [5-6, 10, 134, 9-11]. 
Despite this, prognostic SSEPs are not considered an essential investigation in all UK intensive 
care units (ICU) and MRI or EEG is more commonly used [15]. Perhaps because SSEP testing 
requires expertise in implementation and interpretation, which is not available nationally, and 
the moderate interobserver variation (IOV) amongst experts when interpreting the N20 as 
absent [16-18]. In addition, albeit rarely, absent N20 responses incorrectly predict poor 
outcome if performed during targeted temperature management (TTM) (24-48 hours of body 
core-temperature reduction to 33-34⁰C) or <72 hours post CA, a finding more frequently 
reported in the paediatric age range [8, 19-22]. Current guidelines suggest prognostication in 
comatose CA patients with absent or extensor motor response to pain should not be performed 
<72 hours after return of spontaneous circulation (ROSC) [610]; however, early prognosis is 
preferred as decisions regarding withdrawal of life sustaining therapy may already be firmly 
established at 72 hours post CA and thus for SSEPs to be beneficial in the paediatric intensive 
care setting they must be reliable early and during TTM. Several studies report on the reliability 
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of SSEP performed during TTM (33-34⁰C) [23-26,] but current opinion suggests SSEPs should 
only be performed >72 hours after ROSC if treated with TTM (33-34⁰C) [46]. The objective of 
this study was to assess whether blinded SSEPs could accurately predict neurological outcome 
30 days post cardiac arrest (CA) in children and whether TTM (33-34⁰C) or the timing of the 
SSEP test affected its prognostic accuracy. 
Methods 
This single centre prospective cohort study was performed in a tertiary paediatric ICU (PICU) in 
the UK. Patients included were aged between 0 – 15 years, admitted to PICU following CA with 
cardiopulmonary resuscitation (CPR) duration greater than three minutes and remained 
comatose. Patients were excluded due to lack of parent/guardian consent or unwillingness of 
the patient’s Consultant to allow inclusion in the study; if they were ineligible for SSEP 
monitoring (e.g. spinal cord injury) or if the patient had a pre-existing condition affecting the 
integrity of the SSEP (e.g. a peripheral neuropathy). Informed consent was obtained from the 
child’s parent/guardian within 24 hours of CA. The study was approved by the Coventry & 
Warwickshire Regional Ethics Committee, UK [REC REF no. 13/WM/0123]. 
Standard post cardiac arrest management during part of the study recruitment period (2013-
2014) included TTM, utilising a core temperature of 33-34⁰C for 24 hours with active re-
warming over 16 hours to 37-37.5⁰C. Patients were sedated with Morphine and Midazolam 
infusions and received Rocuronium to achieve neuromuscular blockade if required to avoid 
shivering or ventilator synchrony during TTM. 
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Serial SSEPs were recorded in line with published guidelines [27], with the exception of 
recording a far field subcortical potential, at 24, 48 and 72 hours post-CA by stimulating the 
Median nerve aspect of the wrist or elbow and recording cortical evoked potentials (EP) from 
C3’ and C4’ (located 2cm posterior to C3/4 International 10:20 placement); spinal EPs from 
cervical vertebra 2 or 5 and peripheral EPs from Erb’s point (located at the upper trunk of the 
brachial plexus, 2-3cm above the clavicle) or the median aspect of the elbow if access to Erb’s 
point was not possible. The stimulus was administered via bipolar surface electrodes at a rate 
of 2.1Hz. Stimulus duration was 0.2 – 0.5ms, set at an intensity 1.5 times higher than motor 
threshold, or at 25mA if neuromuscular junction blocking agents were administered. Two sets 
of 150 summated evoked potentials were recorded within 3Hz and 3KHz low and high 
frequency filers using either Medelec Synergy (Viasys, Woking, UK) or Myoquick matrix line 
(Micromed, Working, UK) recording software. 
SSEPs were analysed by one Consultant Clinical Neurophysiologist (LN) and documented as 
“absent” (defined as a bilaterally absent N20 response after left and right Median nerve 
stimulation in the presence of peripheral or cervical responses), “present” (Cortical N20 
response after left and right Median nerve stimulation) or “indeterminable” (technically 
insufficient recording). In the case of a unilateral indeterminable SSEP, the contralateral 
response was used. The reporting Clinical Neurophysiologist was blinded to all patient details 
except limb length and core temperature. PICU staff were blinded to SSEP results.  
Neurodevelopmental and survival outcome was assessed by one trainee assessor (TR) using the 







face or telephone interviews with parent/guardian. PCPC is a 6-point scale (1- normal, 2- mild 
disability, 3- moderate disability, 4- severe disability, 5- coma or vegetative state, 6- death) and 
primary outcome was poor neurodevelopmental outcome (PCPC 4-6). 
Secondary outcomes questions were whetherif the presence ofpresent SSEPs predicted good 
neurodevelopmental outcome (PCPC 1-3) and the effect SSEP timing and TTM (33-34°C) had on 
the SSEP. 24-hour SSEPs were performed during TTM (33-34⁰C), 48-hour during the re-warming 
phase, and 72-hour when normothermic. 
Peak onset latency of cortical EPs, nerve conduction velocities and SSEP interpretability (i.e. too 
much artefact to prevent analysis) were recorded for each trace. Demographic and Utstein 
defined resuscitation variables [29] (age, sex, location of arrest, first monitored cardiac 
arrhythmia, time to return of spontaneous circulation (ROSC)) were collected for each patient.  
Statistical analysis 
Basic summary statistics are reported for the entire study population. Binary and categorical 
variables are summarised using numbers and percentages. Continuous variables are 
summarised using mean and standard deviation (for normally distributed variables) or median 
and interquartile range (for variables that are not normally distributed). The choice of summary 
statistics for continuous variables was made after viewing a histogram. For each outcome, we 
formed a 2x2 table of outcome against prediction. From this table, we calculated sensitivity 
(true positive rate), specificity (true negative rate), positive predicted value, negative predicted 
value, and rates of type I and II error. The combination of these measures allows us to provide 










examine whether there was a difference in onset latency and conduction velocity recorded 
from the same patient at any of the three different time points during their care (24, 48, 72 
hours). A p value <0.05 was considered significant.  Descriptive statistics were analysed 
according to their distribution. Normally distributed, continuous data was reported as mean 
and standard deviations (SD). Non-parametric data was reported as median and interquartile 
ranges (IQR). Discrete data was expressed as a percentage. Sensitivity, specificity, predictive 
values and rates of type I and II error were calculated to estimate SSEP prognostic accuracy and 
Fisher’s exact test analysed the significance of differences in proportions. P values <0.05 and 
<0.01 were considered significant and marked with * and ** in tables, respectively. A binomial 
approximation was made when calculating 95% confidence intervals (CI) for the predictive 
measures. were calculated using the binomial distribution of proportions and Aall analysis was 
performed using Minitab 17.  
Results 
Between August 2013 – December 2014, 18 patients were admitted to PICU following CA, 16 
met inclusion criteria (as two had CPR CA <3 minutes following CA) and 12 (75%) were 
successfully recruited. The families (n=3) and lead Consultant’s lack of consent (n= 1) were the 
reasons for exclusion. Baseline demographics, resuscitation factors and outcomes are 
presented in Table 1. A significant proportion (92%) were male and the majority received TTM 
(33-34°C) (83%). Five (42%) patients had poor outcome (PCPC 4-6), of which four (33%) died 
and one was moderately disabled 30 days post CA. Cause of death was hypoxic ischaemic injury 
following CA in all patients. Ventricular fibrillation (33%) and asystole (33%) were the most 
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common presenting rhythms. Seven (58%) patients survived, three (33%) with good outcome 
(PCPC-1), three (33%) with minor disabilities and one (8%) with moderate disability (PCPC-3). 
 
Median time from CA onset to first, second and third SSEP recordings were 25 hours (IQR: 24.3 
-28.0), 48 hours (IQR: 46.6– 50.8) and 73 hours (IQR: 70.0 – 74.5), respectively. Mean body 
temperature was 34.0⁰C (SD 0.8) during TTM (33-34⁰C) period, 36.3⁰C (SD 1.4) during re-
warming and 36.7⁰C (SD 0.4) when normothermic. 
 
68 SSEPs (34 from left limb stimulation, 34 from right limb) were recorded in 12 patients: 20 
during TTM (33-34⁰C), 20 during re-warming and 28 whilst normothermic (36.5-37.5⁰C). 
Progressively more SSEPs were available for analysis over serial recordings [Table 2] for two 
reasons: a change in PICU practice meant TTM (33-34°C) was not administered in two patients 
and artefact contamination appeared more problematic in 24- and 48-hour recordings, thus 13 
SSEPs (recorded in 3 patients) were deemed indeterminate during TTM (33-34⁰C ) (n= 6), re-
warming (n=5) and normothermia (n=2). Absent/present interpretations were reached in all 
patients before 72 hours. In total, 16 (in 8 patients), 19 (in 10 patients) and 20 (in 11 patients) 
SSEPs were analysed in 24-, 48- and 72-hour groups, respectively [Table 2].  
 
An absent cortical SSEP incorrectly predicted poor outcome in one patient [Figure 1] (88% 
Specificity; 95%CI:, 53%-98%) therefore the rate of false predictions was 13% (95%CI, : 0%-45%) 
and PPV was 88% (95%CI:, 45%-100%).  Present cortical SSEPs correctly predicted good 


















97%).  Specificity and PPV were lower in 72-hour recordings because 24- and 48-hour SSEPs of 
the false positive were interpreted as indeterminate due to excess artefact and excluded from 
analysis. The presence or absence of cortical potentials at 24-hours was consistent within serial 
recordings. When warmed from TTM (33-34°C), peak onset latency of peripheral, spinal and 
cortical evoked potentials decreased and nerve conduction velocity (both peripheral and 




In this small prospective cohort study, Blinded blinded SSEPs predicted outcome accurately in 
most patients and the timing of the SSEP test or temperature of the patient did not significantly 
impact on prognostic utilityaccuracy. However, one patient with absent cortical potentials at 72 
hours post CA had good (PCPC-3) neurological recovery. If this patient’s SSEPs were not blinded 
to PICU clinicians, and considered in prognostic algorithms, it may have resulted in a decision to 
withdrawal life-sustaining therapy. Although Wwe therefore advise caution when using SSEPs in 
isolation to predict poor outcome in paediatric comatose CA survivors, these findings are 
overstated by our small sample size and conclusions must be interpreted with this in mind. 
 
Bilaterally absent cortical SSEPs have been reported in paediatric, traumatic brain injury (TBI), 
CA and meningitis “good-outcome” patients [5-7, 10, 13,4,7,9-10 30-31]. These studies highlight 
the importance of delaying prognosis to ensure electrical interference, intraobserver variation 















accounted for and minimised, false positives still occur infrequently [19-22]. Absent SSEPs in 
paediatric CA following TBI have lower specificity in predicting poor outcome when compared 
to brain injury as a result of hypoxic ischaemic encephalopathy (HIE), and the presence of 
cortical SSEPs has a higher diagnostic odds ratio to predict awakening when compared to HIE 
[913,32]. Even though a TBI patient in the present study had poor outcome correctly predicted 
at 24, 48 & 72 hours post CA, SSEPs performed within 24 hours of TBI should be repeated 
[1112] as TBI contributed to 8% [1/12 patients] of an already small sample size of study 
participants.  
 
Our false positive had no known comorbidities which could explain an absent SSEP. Sedation 
was not excessive and not significantly altered during TTM (33-34⁰C). Technically, the SSEP was 
difficult to record and deemed indeterminate at 24- & 48-hour recordings due to interference 
but was interpreted as absent at 72-hours (See figure 1).  
 
Interpreting serial SSEPs between hypothermic (TTM (33-34⁰C)) and normothermic conditions 
did not alter the prognostic accuracy of the test. Since 2002, a growing body of literature 
emerged supporting survival in CA patients treated with TTM (33-34⁰C) which raised concerns 
regarding the accuracy of prognostic tests performed during hypothermia [7]. Several studies 
addressed this issue [24-26, 30] and guidelines support SSEP prognostication at 24 hours if no 
TTM (33-34⁰C )C) is used, and at 72-hours if used [2,45-6]. Rationale for delayed prognosis was 
the increased rate of false predictions seen in TTM (33-34⁰C )C) treated patients. These were 
attributed to excessive artefact and an increased rate of IOV. In the current study, an accurate 
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prognosis was determined at 24-hours in the majority (66%) of patients. However, exclusion of 
SSEP traces due to excessive artefact was highest in the 24-hour group (n=6) in comparison to 
the 48- (n= 5) and 72-hour (n=2) group. During rewarming, increasing body temperature was 
associated with decreasing latency of evoked potentials and increase in peripheral and central 
nerve conduction velocity in keeping with previous studies [23]. The lack of statistical 
significance could be due to small sample size. 
 
There are potential limitations to the study. First, IOV was not formally assessed and has been 
described as moderate to substantial when interpreting prognostic SSEPs [16-18] and should be 
addressed in future studies. Secondly, PCPC is a simple and reliable measure of 
neurodevelopmental outcome and is commonly used in paediatric cardiac arrest studies (28, 
34); however, the broad categories may limit its ability to accurately differentiate good and 
poor outcome. There remains disagreement as to whether PCPC 1-2 or 1-3 demonstrates a 
good outcome and whether PCPC 4 is good/poor outcome [913, 35-40]. Median age of children 
assessed with PCPC is 3 years [28] and uses school-based and age-specific criteria to assess 
good outcome (PCPC 1-3). 33% of our cohort were neonates (one of which had outcome falsely 
predicted) and making the distinction between good and bad outcome categories was 
challenging. Confidence intervals for proportional estimates are wide (48% - 100%), indicating 
we have little knowledge of the true prognostic accuracy of SSEPs in this cohort. Recruiting 










UnblindedPr prognostic SSEPs in adult and paediatric HIE studies are close to 100% specific 
when prognosticating poor outcome after coma [2-12]. In paediatric age (>30 days - <19 years), 
97% of patients with absent SSEPs and 92% of patients with present SSEPs have outcome 
predicted correctly [913] which is similar to presented findings. Sensitivity is low in adults (45-
48%) [54] and paediatrics (70-80%) [913, 32] because present cortical responses do not ensure 
good outcome [41]. Sensitiivity in paediatrics  may be higher due to infant brain plasticity and 
the marked difference in favourable ICU prognosis in comparison to adults [913]. We found 
that a present cortical SSEP identified the majority (86%) of good outcome patients although 
this may be an optimistic estimate in our small, heterogenous sample.  
A strength of this study was that SSEP results were successfully blinded from clinical staff caring 
for the patient and clinical data from the Neurophysiologist interpreting SSEPs. The rate of false 
predictions was higher than previously described but we must emphasise that findings are 
overstatedlikely due to small sample size. despite a small, heterogeneous sample, and wWe 
believe the current findings add to the clinical utility of prognostic SSEPs. However and  
multimodal approaches to CA coma prognostication are essential in order to minimise the risk 
of making false predictions.  
Accurate prognosis of comatose CA children is challenging and false positive SSEP results can 
occur. Our study supports the utility of SSEPs to predict favourable and unfavourable 
neurological outcome irrespective of the time performed or patient temperature. However, 
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Figure 1: 72-hour right and left limb SSEPs interpreted as bilaterally absent in a 
patient with good neurological recovery (PCPC- 3) 30 days post CA. Peripheral, 
spinal and cortical waveforms displayed in top, middle and bottom lines, 
respectively 
Figure 1: Top: 72-hour right and left limb SSEPs interpreted as bilaterally absent in a 
patient with good outcome (PCPC- 3) 30 days post CA. Bottom: 72 hour right and 
left limb SSEPs interpreted as bilaterally present in a patient with good outcome 
(PCPC) Present peripheral, spinal and cortical (PCPC- 1). Peripheral, spinal and 















n = 12 
 




Gender, male (%) 11 (92) 












Location of Cardiac Arrest (n%) 
 In-hospital 
 Out-of-Hospital 
                    
         3  (25) 
9 (75) 
TTM (33-34⁰C ) use, n (%) 10 (83) 
ROSC, mins, median (IQR) 25 (14-39) 














Table 1:  Demographics and resuscitation factors of the 12 patients recruited: VF – Ventricular fibrillation, CA – Cardiac arrest, 
PEA – Pulseless electrical activity, IQR- Interquartile range, CPR – Cardiopulmonary resuscitation; TTM – Targeted Temperature 









Interpretation of SSEP Outcome 
/ 
PCPC Score 
24 Hour 48 Hour 72 Hour 
LEFT RIGHT LEFT RIGHT LEFT RIGHT 
S01 Ind. Ind. Ind. Ind. Absent Absent Moderate 
disability / 3 
S02 Present Present Present  Present Present Present Mild disability 
/ 
 2 
S03 Ind. Ind. Ind. Present Ind. Present Normal / 
1 
S04 Absent Absent Absent Absent Absent Absent Death / 
6 
S05 Present Present Present Present Present Present Normal / 
1 
S06 Present Present Present Present Present Present Normal / 
1 
S07 Absent Absent Absent Absent Absent Absent Severe 
disability / 4 
S08 Present Present Present Present Present Present Mild disability 
/ 
2 
S09 Ind. Ind. Ind. Ind. Ind. Absent Death / 
6 
S10 Absent Absent Absent Absent Absent Absent Death / 
6 
S11 N/A N/A Absent Absent N/A N/A Death / 
6 







8 8 9 10 9 11 26 29 
Total 16 19 20 55 
Table 2: Interpretation of serial SSEPs performed after left and right-limb stimulation and 30 day outcome assessed via PCPC 
score. Total SSEPs recorded from left and right limbs over serial recordings detailed separately. N/A: Not performed and patient 

























Sensitivity, %  
(95% CI) 
100 
 (48 - 100) 
100 
 (56 - 100) 
100 
(56 - 100) 
86 
(49 to 97) 

















(45 - 100) 
100 
 












0 0 13 
(0-45) 
0 
Table 3: Predictive power of absent and present cortical SSEPs at 24, 48 and 72 hours post cardiac arrest. SD- Standard 
deviation, CI- Confidence interval, PPV- Positive predictive value, NPV- Negative predictive value, FPR- False positive rate**- 















Peak onset latency, ms 
Mean (SD) 
Nerve conduction velocity, m/s 
Mean (SD) 



































Table 4: Combined left and right peak onset latency of peripheral, spinal and cortical evoked potentials following median nerve 
stimulation at the wrist; peripheral and central nerve conduction velocities.* p<0.05 
 
 
 
 
